五种新型唑类抗真菌药物
110
been
the medieal market abroad and
shown notable e伍cacy w/th
obvious toea/side
effects in
the treatment of
superficial如ng鲥jnfeetion
are
including dermatophytosis.Two triazoles including pramiconazole and ravuconazole although they have pmved
和特比萘芬低,说明该药具有较强效的抗马拉色菌
作用。
Uchida等㈤给予1%卢立康唑乳膏外用治疗,治疗后
多次行真菌培养,结果均为阴性,而阴性对照组均为
拉诺康唑短期外用3 d治疗豚鼠足癣后发现, 1%拉诺康唑的疗效与1%特比萘芬相当(菌学清除
率均为20%),外用7天则可获得更高的真菌清除
阳性。提示卢立康唑外用治疗足癣具有明显的抗菌
a
al
novel histone milestone(H3-TlI).GelI Cycle。2008,7(11): Maciel R,da Costa RF,de Oliveira FM,et a1.Protein
sites
[9] Aide,on Gk Joenje H,Varon R.et a1.Seckel syndrome exhibits
(MIC≤0.031~0.13斗咖1),其抗菌能力高于特比
萘芬、利拉萘酯及联苯苄唑等药物。另外,该药对马拉 色菌也有较强作用,其MIC为0.004—0.16斗g,“, 不弱于酮康唑。Uchida等…也在体外药敏实验中发 现,卢立康唑抗马拉色菌的能力优于联苯苄唑和特 比萘芬。在须癣毛癣菌感染足部皮肤的豚鼠模型上,
leads
to
age.
stem
cell
1065.Cell Stem Cell,2007.1
claspin-dependent but ATR/ATM—and RBdl7.independent checkpoint response in HeLa cells.Cancer Res.
MH.Rosen JM.Chkl vemu¥Cde25:chking
170
国匠皮肤丝痘堂基盍垫!!生5旦筮31鲞筮3趣丛』堕墅g趔!塑£塑!,丛型垫!!:一!Q!:32:奠Q:3
visualized by glycerol spray/low voltage microscopy.J Biol Chera. 2002,277(18):15233.15236. B56delta phosphatase control
过度型足癣患者,结果显示,单用拉诺康唑的临床改
善率为70%,治疗后4周和12周的真菌清除率分 别为5%和70%。而合用10%尿素软膏患者的临床 改善率和12周时的真菌清除率均为95.7%,提示合
得两组的临床有效率分别为91.5%和91.7%,菌学 阴性率分别为76.1%和75.9%,差异无统计学意义,
【关键词】眯唑类;三唑类;研究;治疗应用
nVe novel
azole柚鲕lllgaI agen缸WH/vc k,L彤Wei一如Institute
and Peking Union
of Dermatology,Chinese
Academy
of Med&d,Sciences
Medwd cD如伊,Nanjing 210042.China
基金项目:国家科技莺大等项(2009zx09303—005) 作者单位:210042南京。中国医学科学院北京协和医学院皮肤病 研究所 通信作者:刘维达,Email:liumyeo@hotmail.cos 本文主要缩写:M1C:最低抑菌浓度,MIC∞:最低50%的抑菌浓
现,需要不断研制新型抗真菌药,其中唑类便是一大
man80ni
GCN5.
[10]
Yan S.MichacI WM.TopBPI and DNA polymerase-alpha direct. 1y recruit the 9.1.1 complex
to
Biochem Biophys Res Commun,2008,370(1):53.56.
stalled DNA replication forks.J
uses
【Key words】Imidazoles;Triazoles;Research;Therapeutic
在抗真菌药物中,唑类药物是一个大家族。自
DOI:10.3760/cma.j.issn.1673_4173.201 I.03.016
从20世纪60年代末咪康唑问世以来,唑类药物便 成为临床治疗真菌感染的主要药物。随着耐药的出
[7] Pa而lla—Castellar ER.Arlander SL
L嘶a/9-I.t for
DNA
[15]
TaLI【ai
damage"the Rad9.Husl.Radl(9-1-1)clamp complex.DNA Re- pair(Amst),2004,3(8.9):1009.1014.
checkpoint
而发挥抗菌作用。 将14C标记的拉诺康唑乳膏外用大鼠后背光滑 皮肤,24 h后仍可以在角质层中测得83%总放射 量,甚至在96 h后仍可以检测到放射性。另外在24 或48 h后还测得提取的放射性物质中有超过94% 是以原形成分存在,而不是代谢物。说明该药具有较 好的渗透及滞留作用【6】。 Ghannoum等[7]选取红色毛癣菌、须癣毛癣菌和 絮状表皮癣菌作为研究对象,测得拉诺康唑最低 50%的抑菌浓度(MIC50)值为0.002—0.004斗g/ml,最 低90%的抑菌浓度(MIC帅)值为(O.002—0.004斗加Ill, 均比特比萘芬低。Uchida等【2】发现拉诺康唑对糠秕 马拉色菌、合轴马拉色菌和斯洛菲马拉色菌MIC的 几何均值分别为1.3、0.1和0.9 mCL,比联苯苄唑
研究热点。
1卢立康唑(1uliconazole) 卢立康唑是日本Nihon Nohyaku公司于1995年
度。Mlcm:最低90%的抑菌浓度
万方数据
国医座瓞性痘堂盘盘放!!堡5月筮≥2鲞筮3期堕Lj旦£丝g趔!£鳇盟国,M塑垫!!:y丛:32:理Q:≥
171
研制的一种咪唑类抗真菌新药,2005年在日本上 市。卢立康唑通过抑制麦角固醇合成途径中14一甲
Shiotani B,Kobayeshi M。Watanabe M,et a1.Involvement of the
Genes
[19]
Dev,2008.22(3):297.302.
A。et
ATR—and ATM-dependent checkpoint responses in cell cycle at- rest evoked by pierisin—1.Mol Cancer Res,2006,4(2):125.133. [12] Bedrlguez—Bravo V,Guaita-Esteruelas S,norensa R.et a1.Chkl.
Karnitz
in
regulating 14-3—3 release from Cde25
to
mitosis.Cell,2006,127(4):759.773.
H,Tominaga k Motoyama N.el a1.Aberrant eell cycle funetion and early embryonic death in CIlkl(4-)
deep
fun#infections.They
structure.Three
new
be
divided into
two
groups,i.v.,e
imidazoles
ehemieal
imidazoles
including luliconazole.1anoconazole and flutrimazole have
[18]
Toledo LI,Murga M,Gufie口ez—Martinez P.et a1.ATR signaling
Cell Biol,2009.184(6):793.804.
can drive cells
into
senescence
in
the absence of DNA breaks.
[11]
cellular features demonstrating defects
in
1555.1559.
the ATR.signalling
[17】
de
Moraes
pathway.Ham MoI Genet。2004,13(24):3127—3318.
acetylation
mediated
by
Schistosoma
to
still in clinical trials. deep fungal
be
as
safe
new
and
effective in the treatment of
superficial and
infection,
and
have shown some potential
antffungal agents.
treatment choice for superficial and and triazoles,according
to
on
Corresponding author."LIU Wei-da,Email:liumyco@hotmail.com
【Abstract】Azoles
can
are
a
primary